Premium
Delayed neutrophil engraftment in patients receiving Daratumumab as part of their first induction regimen for multiple myeloma
Author(s) -
Al Saleh Abdullah S.,
Sidiqi M. Hasib,
Gertz Morie A.,
Muchtar Eli,
Lacy Martha Q.,
Warsame Rahma M.,
Gonsalves Wilson I.,
Kourelis Taxiarchis V.,
Hogan William J.,
Hayman Suzanne R.,
Kapoor Prashant,
Buadi Francis K.,
Dispenzieri Angela,
Dingli David,
Kumar Shaji K.
Publication year - 2020
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.25654
Subject(s) - daratumumab , multiple myeloma , medicine , regimen , induction therapy , oncology , induction chemotherapy , immunology , chemotherapy , lenalidomide